| Number | Date | Country | Kind |
|---|---|---|---|
| 9424408 | Dec 1994 | GBX | |
| 9504891 | Mar 1995 | GBX | |
| 9510042 | May 1995 | GBX |
This continuation is a 371 of PCT/JP95/02428 filed Nov. 20, 1995.
| Filing Document | Filing Date | Country | Kind | 102e Date | 371c Date |
|---|---|---|---|---|---|
| PCT/JP95/02428 | 11/29/1995 | 5/30/1997 | 5/30/1997 |
| Publishing Document | Publishing Date | Country | Kind |
|---|---|---|---|
| WO96/16981 | 6/6/1996 |
| Number | Date | Country |
|---|---|---|
| A 394989 | Oct 1990 | EPX |
| A 0 446 699 | Sep 1991 | EPX |
| WO A 92 22569 | Dec 1992 | EPX |
| A 0 525 420 | Feb 1993 | EPX |
| Entry |
|---|
| D. Hagiwara et al, "3tudies on Neurokinin Antagonist, 3, Design and Structure-Activity Relationships or New Branched Tripeptides Nalpha, (Substituted L-aspartyl, L-ornithyl, or L-lysyl)-N-(phenylmethyl-L-phenylalaninamides as Substance P Antagonists", J. Med.Chem. vol. 36 1993, pp. 2266-2278 (XP002006315). |
| D. Hagiwara et al: "Studies on Neurokinin Antagonists. 4", (see Table 1), J. Med. Chem, vol. 37, Jun. 21, 1991, pp. 2090 99, (XP002006316). |